Acetylsalicylic acid in primary and secondary prevention of late diabetic complications

Dorota Zozulińska; Aleksandra Uruska; Bogna Wierusz-Wysocka

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

4/2007
vol. 10

Send email

Copy url:

abstract:

Acetylsalicylic acid in primary and secondary prevention of late diabetic complications

Dorota Zozulińska

,

Aleksandra Uruska

,

Bogna Wierusz-Wysocka

Przew Lek 2007; 4: 84-91

Online publish date: 2007/07/09

View full text Get citation

Vascular complications are the main cause of disability and preterm death among young people with diabetes mellitus (DM). Mortality because of cardiovascular disease (CVD) in people with glucose metabolism disturbances is 2-4 times higher than in the general population. In diabetic patients disturbances in function and quality of platelets are characteristic. Use of acetylsalicylic acid (ASA) in prophylaxis of CVD has been recommended for years also in DM. However, there are still controversies regarding the optimal dose for this group of people. ASA resistance contributes to difficulties in treatment. The effect of ASA on micro- and macroangiopathic complications makes antiplatelet therapy in DM an essential, clinical problem.

keywords:

Acetylsalicylic acid in primary and secondary prevention of late diabetic complications

Dorota Zozulińska , Aleksandra Uruska , Bogna Wierusz-Wysocka

acetylsalicylic acid, diabetes mellitus, prevention, chronic diabetic complications

Dorota Zozulińska

,

Aleksandra Uruska

,

Bogna Wierusz-Wysocka